LUNG NEOPLASMS

This study tested whether an oral medicine called BI 907828 could help control advanced cancers of the bile duct, pancreas, lung, or bladder that had a specific genetic pattern (MDM2 amplified, TP53 wild-type) and had stopped responding to standard treatments. All 99 participants…

This large, completed Phase 3 trial tested if adding a new drug (vibostolimab) to an existing immunotherapy (pembrolizumab) worked better than the standard single drug for people with a specific type of advanced lung cancer (PD-L1 positive NSCLC). Over 1,200 participants were ran…

This study monitored the safety and effectiveness of the lung cancer drug Vizimpro in real-world patients in Korea after it was approved for use. Doctors observed 188 patients with a specific genetic type of advanced lung cancer who were prescribed the drug as part of their norma…

This study tested a special near-infrared camera system to help surgeons see blood flow in real-time during minimally invasive lung and esophageal cancer surgeries. The goal was to see if this tool could help surgeons better identify healthy tissue and avoid complications like le…

This study tested a blood test designed to detect specific genetic changes in lung cancer cells. The goal was to see if this 'liquid biopsy' could reliably match patients to targeted therapies, avoiding the need for invasive tissue biopsies. Researchers enrolled 206 patients with…

This study tested three experimental tools designed to help doctors insert biopsy needles at the correct angle during CT-guided biopsies for cancer. The goal was to see if these tools—a laser pointer, a plastic block with pre-drilled holes, and a mobile device—could improve accur…

This study tested whether a special nursing program could help people with advanced small cell lung cancer better handle their treatment. 200 patients receiving standard chemo-immunotherapy were split into two groups: one received care from a dedicated team of nurses, doctors, an…

This study tested whether involving family members in a structured palliative care program could improve the well-being of patients with advanced lung cancer. Over 8 weeks, 110 patients received either standard care or this special family-supported program. Researchers measured q…

This study tested whether a remote monitoring app could improve quality of life for people with advanced cancer. It involved 411 adults with metastatic breast, lung, colorectal, or prostate cancer. Researchers compared patients using the app to report symptoms from home against p…